ABSTRACT
In this comparative trial, outpatients with acute sinusitis were randomly assigned to receive levofloxacin (500 mg orally once daily) or amoxicillin-clavulanate (500/125 mg orally 3 times daily) for 10 to 14 days. The success rates (cured and improved) 2 to 5 days after the end of treatment were 88.4% for the 267 clinically evaluable patients who received levofloxacin and 87.3% for the 268 clinically evaluable patients who received amoxicillin-clavulanate. Drug-related adverse events occurred in a smaller percentage of patients in the levofloxacin treatment group (7.4%) than in the amoxicillin-clavulanate treatment group (21.2%). The most common of these were nausea, diarrhea, vaginitis, and abdominal pain for levofloxacin-treated patients and diarrhea, vaginitis, nausea, genital moniliasis, abdominal pain, vomiting, and flatulence for amoxicillin-clavulanate-treated patients. The results of this study show that once-daily administration of levofloxacin is as effective and better tolerated than amoxicillin-clavulanate administered 3 times daily for treating acute sinusitis in adult outpatients.
Subject(s)
Amoxicillin-Potassium Clavulanate Combination/therapeutic use , Anti-Infective Agents/therapeutic use , Drug Therapy, Combination/therapeutic use , Levofloxacin , Ofloxacin/therapeutic use , Sinusitis/drug therapy , Acute Disease , Administration, Oral , Adolescent , Adult , Aged , Aged, 80 and over , Ambulatory Care , Female , Gastrointestinal Diseases/chemically induced , Humans , Male , Middle Aged , Treatment Outcome , Vaginitis/chemically inducedABSTRACT
Electrodermal responses in the facial region of freely moving rats were recorded bilaterally. After a nociceptive stimulus (ammonia vapor exposure), the response (a transient negative potential followed by a longer-lasting positive potential) attained a similar amplitude on both sides. Surgical sympathetic denervation of facial skin by ipsilateral superior cervical ganglionectomy (SCGx) significantly decreased the electrodermal response. When an inferior cervical ganglionectomy was performed in addition to SCGx, a further decrease in electrodermal response was observed. Pretreatment of unilaterally SCGx rats with atropine blunted the electrical response in the control side to levels similar to those found in the SCGx side. Treatment with phenoxybenzamine or propranolol was ineffective. Skin potential responses were measured in adult rats administered with clomipramine from the 8th to the 21st day of life and exhibiting a long-lasting syndrome resembling human depression. Clomipramine-injected rats developed larger skin potential responses to sound stimulation than controls while responses to ammonia vapor were similar in both groups, as well as the habituation rate after repetitive exposure to ammonia vapor. The results indicate that some of the altered electrodermal responses found in depressed patients are detectable in the clomipramine animal model of endogenous depression.
